In agreement with previously published results (Hoffmann et al, 2002), we observed significantly lower percentage of Anx V+CD4+ than CD8+ T cells in SCCHN patients and in NC (Figure 6A). The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.